HCPCS Level IIdrugActive
J7200
Factor ix recombinan rixubis
BETOS: O1E
Effective: 2015-01-01
Referenced in 5 policies
Description
Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Rixubis
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.